Your browser doesn't support javascript.
loading
Mostrar: 20 | 50 | 100
Resultados 1 - 15 de 15
Filtrar
Mais filtros











Intervalo de ano de publicação
1.
J Biophotonics ; 14(6): e202000487, 2021 06.
Artigo em Inglês | MEDLINE | ID: mdl-33638279

RESUMO

This study evaluated the optical absorbance spectrum of human monocytes, neutrophils and lymphocytes polarized, or not, to the inflammatory or immunoregulatory phenotypes. Peripheral human blood leukocytes were isolated and polarized (10 ng/mL) with LPS or IL-4 + LPS for 2 hours. After polarization, cells were washed and incubated for an additional 24 hours (monocytes and lymphocytes) or 12 hours (neutrophils). Next, cells were collected to evaluate the optical absorbance spectrum. The three types of leukocytes exhibited absorbance in the region from 450 to 900 nm, with greater absorbance at wavelengths lower than 570 nm. Lymphocytes had a second region of greater absorbance between 770 and 900 nm. Inflammatory monocytes and lymphocytes showed increased absorbance of blue, green and yellow wavelengths (monocytes), as well as red and infrared wavelengths (monocytes and lymphocytes). Immunoregulatory polarization altered the absorbance of monocytes and lymphocytes very little. Neutrophils treated with LPS or LPS + IL-4 exhibited lower absorbance at wavelengths higher than 575 nm compared to untreated cells. The present findings showed that leukocytes exhibit greater absorbance in regions of the spectrum that have not been much used in photobiomodulation (PBM), and the polarization of these cells can affect their capacity to absorb light. Taken together, these results suggest new perspectives in the use of PBM in the clinical setting depending on the wavelengths and the stage of the inflammatory process.


Assuntos
Leucócitos , Monócitos , Humanos , Linfócitos , Neutrófilos , Fenótipo
2.
Oncotarget ; 9(37): 24766-24777, 2018 May 15.
Artigo em Inglês | MEDLINE | ID: mdl-29872504

RESUMO

Mesenchymal stem cells (MSC) display tumor tropism and have been addressed as vehicles for delivery of anti-cancer agents. As cellular components of the tumor microenvironment, MSC also influence tumor progression. However, the contribution of MSC in brain cancer is not well understood since either oncogenic or tumor suppressor effects have been reported for these cells. Here, MSC were found capable of stimulating human Glioblastoma (GBM) cell proliferation through a paracrine effect mediated by TGFB1. Moreover, when in direct cell-cell contact with GBM cells, MSC elicited an increased proliferative and invasive tumor cell behavior under 3D conditions, as well as accelerated tumor development in nude mice, independently of paracrine TGFB1. A secretome profiling of MSC-GBM co-cultures identified 126 differentially expressed proteins and 10 proteins exclusively detected under direct cell-cell contact conditions. Most of these proteins are exosome cargos and are involved in cell motility and tissue development. These results indicate a dynamic interaction between MSC and GBM cells, favoring aggressive tumor cell traits through alternative and independent mechanisms. Overall, these findings indicate that MSC may exert pro-tumorigenic effects when in close contact with tumor cells, which must be carefully considered when employing MSC in targeted cell therapy protocols against cancer.

3.
Oncotarget ; 8(12): 19192-19204, 2017 Mar 21.
Artigo em Inglês | MEDLINE | ID: mdl-28186969

RESUMO

Medulloblastoma is a highly aggressive pediatric brain tumor, in which sporadic expression of the pluripotency factor OCT4 has been recently correlated with poor patient survival. However the contribution of specific OCT4 isoforms to tumor aggressiveness is still poorly understood. Here, we report that medulloblastoma cells stably overexpressing the OCT4A isoform displayed enhanced clonogenic, tumorsphere generation, and invasion capabilities. Moreover, in an orthotopic metastatic model of medulloblastoma, OCT4A overexpressing cells generated more developed, aggressive and infiltrative tumors, with tumor-bearing mice attaining advanced metastatic disease and shorter survival rates. Pro-oncogenic OCT4A effects were expression-level dependent and accompanied by distinct chromosomal aberrations. OCT4A overexpression in medulloblastoma cells also induced a marked differential expression of non-coding RNAs, including poorly characterized long non-coding RNAs and small nucleolar RNAs. Altogether, our findings support the relevance of pluripotency-related factors in the aggravation of medulloblastoma traits classically associated with poor clinical outcome, and underscore the prognostic and therapeutic value of OCT4A in this challenging type of pediatric brain cancer.


Assuntos
Biomarcadores Tumorais/metabolismo , Neoplasias Encefálicas/secundário , Neoplasias Cerebelares/patologia , Meduloblastoma/patologia , Fator 3 de Transcrição de Octâmero/metabolismo , Animais , Apoptose , Biomarcadores Tumorais/genética , Neoplasias Encefálicas/genética , Neoplasias Encefálicas/metabolismo , Movimento Celular , Proliferação de Células , Neoplasias Cerebelares/genética , Neoplasias Cerebelares/metabolismo , Feminino , Humanos , Meduloblastoma/genética , Meduloblastoma/metabolismo , Camundongos , Camundongos Endogâmicos BALB C , Camundongos Nus , Fator 3 de Transcrição de Octâmero/genética , Prognóstico , Células Tumorais Cultivadas , Ensaios Antitumorais Modelo de Xenoenxerto
4.
Cytotechnology ; 68(4): 1545-60, 2016 Aug.
Artigo em Inglês | MEDLINE | ID: mdl-26358937

RESUMO

Medulloblastoma is a highly aggressive brain tumor and one of the leading causes of morbidity and mortality related to childhood cancer. These tumors display differential ability to metastasize and respond to treatment, which reflects their high degree of heterogeneity at the genetic and molecular levels. Such heterogeneity of medulloblastoma brings an additional challenge to the understanding of its physiopathology and impacts the development of new therapeutic strategies. This translational effort has been the focus of most pre-clinical studies which invariably employ experimental models using human tumor cell lines. Nonetheless, compared to other cancers, relatively few cell lines of human medulloblastoma are available in central repositories, partly due to the rarity of these tumors and to the intrinsic difficulties in establishing continuous cell lines from pediatric brain tumors. Here, we report the establishment of a new human medulloblastoma cell line which, in comparison with the commonly used and well-established cell line Daoy, is characterized by enhanced proliferation and invasion capabilities, stem cell properties, increased chemoresistance, tumorigenicity in an orthotopic metastatic model, replication of original medulloblastoma behavior in vivo, strong chromosome structural instability and deregulation of genes involved in neural development. These features are advantageous for designing biologically relevant experimental models in clinically oriented studies, making this novel cell line, named USP-13-Med, instrumental for the study of medulloblastoma biology and treatment.

5.
Cancer Sci ; 106(9): 1188-95, 2015 Sep.
Artigo em Inglês | MEDLINE | ID: mdl-26250335

RESUMO

In medulloblastoma, abnormal expression of pluripotency factors such as LIN28 and OCT4 has been correlated with poor patient survival. The miR-302/367 cluster has also been shown to control self-renewal and pluripotency in human embryonic stem cells and induced pluripotent stem cells, but there is limited, mostly correlational, information about these pluripotency-related miRNA in cancer. We evaluated whether aberrant expression of such miRNA could affect tumor cell behavior and stem-like traits, thereby contributing to the aggressiveness of medulloblastoma cells. Basal expression of primary and mature forms of miR-367 were detected in four human medulloblastoma cell lines and expression of the latter was found to be upregulated upon enforced expression of OCT4A. Transient overexpression of miR-367 significantly enhanced tumor features typically correlated with poor prognosis; namely, cell proliferation, 3-D tumor spheroid cell invasion and the ability to generate neurosphere-like structures enriched in CD133 expressing cells. A concurrent downregulation of the miR-367 cancer-related targets RYR3, ITGAV and RAB23, was also detected in miR-367-overexpressing cells. Overall, these findings support the pro-oncogenic activity of miR-367 in medulloblastoma and reveal a possible mechanism contributing to tumor aggressiveness, which could be further explored to improve patient stratification and treatment of this important type of pediatric brain cancer.


Assuntos
Neoplasias Encefálicas/genética , Neoplasias Encefálicas/patologia , Proliferação de Células/genética , Meduloblastoma/genética , Meduloblastoma/patologia , MicroRNAs/genética , Antígeno AC133 , Antígenos CD/genética , Linhagem Celular Tumoral , Regulação para Baixo/genética , Glicoproteínas/genética , Humanos , Fator 3 de Transcrição de Octâmero/genética , Peptídeos/genética , Canal de Liberação de Cálcio do Receptor de Rianodina/genética , Esferoides Celulares/patologia , Regulação para Cima/genética , Proteínas rab de Ligação ao GTP/genética
6.
Stem Cells Dev ; 24(22): 2700-8, 2015 Nov 15.
Artigo em Inglês | MEDLINE | ID: mdl-26159230

RESUMO

Misexpression of stem cell-related genes may occur in some cancer cells, influencing patient's prognosis. This is the case of medulloblastoma, a common and clinically challenging malignant tumor of the central nervous system, where expression of the pluripotency factor, OCT4, is correlated with poor survival. A downstream target of OCT4, L1TD1 (LINE-1 type transposase domain-containing protein 1 family member), encodes a novel embryonic stem cell (ESC)-related protein involved in pluripotency and self-renewal of ESCs. L1TD1 is still poorly characterized and its expression pattern and function in cancer cells are virtually unknown. Although normally restricted to non-neoplastic undifferentiated cells and germ cells, we found that high L1TD1 expression also occurs in medulloblastoma cells, reaching levels similar to those found in ESCs, and is correlated with poor prognosis. Conversely to what is reported during normal cell differentiation, when differentiated cells remain healthy, despite L1TD1 downregulation, depletion of L1TD1 protein levels by targeted gene silencing significantly reduced medulloblastoma cell viability, inhibiting cell proliferation and inducing apoptosis. More strikingly, L1TD1 depletion downregulated expression of the neural stem cell markers, CD133 and Nestin, inhibited neurosphere generation capability, and sensitized medulloblastoma cells to temozolomide and cisplatin, two chemotherapeutic agents of clinical relevance in medulloblastoma treatment. Our findings provide insights about the contribution of pluripotency-related genes to a more aggressive tumor phenotype through their involvement in the acquisition of stem-like properties by cancer cells and point out L1TD1 as a potential therapeutic target in malignant brain tumors.


Assuntos
Apoptose , Meduloblastoma/metabolismo , Células-Tronco Neurais/citologia , Proteínas/metabolismo , Antígeno AC133 , Antígenos CD/genética , Antígenos CD/metabolismo , Antineoplásicos/farmacologia , Linhagem Celular Tumoral , Proliferação de Células , Cisplatino/farmacologia , Dacarbazina/análogos & derivados , Dacarbazina/farmacologia , Glicoproteínas/genética , Glicoproteínas/metabolismo , Humanos , Meduloblastoma/patologia , Nestina/genética , Nestina/metabolismo , Células-Tronco Neurais/efeitos dos fármacos , Células-Tronco Neurais/metabolismo , Peptídeos/genética , Peptídeos/metabolismo , Proteínas/genética , Temozolomida
7.
Fisioter. pesqui ; 19(2): 97-102, abr.-jun. 2012. tab
Artigo em Português | LILACS | ID: lil-644506

RESUMO

O objetivo deste estudo foi avaliar a influência da adequação postural em cadeira de rodas na função respiratória de pacientes com distrofia muscular de Duchenne (DMD). Participaram 12 pacientes com diagnóstico de DMD e que possuíam cadeira de rodas adaptada com idade variando de 10 a 22 anos. Cada indivíduo foi avaliado na própria cadeira de rodas e em uma cadeira de rodas padrão, ou seja, sem reclinação ou tilt. As cadeiras dos participantes possuíam adaptações no encosto e no assento, confeccionados de acordo com as especificidades de cada paciente. A avaliação consistiu em mensurar o volume minuto (VM), volume corrente (VC), capacidade vital forçada (CVF), pressões inspiratória (PImax) e expiratória (PEmax) máximas e pico de fluxo expiratório (PFE). Para análise dos dados, foi utilizado o teste t pareado, adotando-se o nível de significância de 0,05. As adaptações resultaram em melhores valores estatisticamente significativos de todos os parâmetros respiratórios: VM (8.963,3 e 10.762,5 mL/min; p=0,028), VC (319,1 e 433,6 mL; p=0,005), CVF (1.476,3 e 1.850 mL; p=0,005), PImax (-41,2 e -51,2 cmH2O; p=0,022), PEmax (29,6 e 36,7 cmH2O; p=0,004) e PFE (162,1 e 185 L/min; p=0,018). Nossos resultados sugerem que a adequação postural em cadeira de rodas influenciou positivamente a função respiratória de pacientes com DMD.


The purpose of this study was to determine the influence of wheelchair positioning aids on the respiratory function of patients with Duchenne muscular dystrophy (DMD). Twelve non-ambulatory DMD patients, between 10 to 22 years of age, were evaluated. They were assessed in their adapted wheelchairs and in a standard wheelchair without tilt or reclining. The wheelchairs of the participants possessed adaptations in the backrest and the seat, made according to the specifics of each patient. Minute volume (MV), tidal volume (TV), forced vital capacity (FVC), maximum inspiratory (MIP) and expiratory pressures (MEP) and peak expiratory flow (PEF) were measured. For data analysis we used the paired t-test adopting the significance level of 0.05. The positioning aids resulted in statistically significant better values of all respiratory parameters: MV (8,963.3 and 10,762.5 mL/min; p=0.028), TV (319.1 and 433.6 mL; p=0.005), FVC (1,476.3 and 1,850 mL; p=0.005), MIP (-41.2 and -51.2 cmH2O; p=0.022), MEP (29.6 and 36.7 cmH2O; p=0.004) and PEF (162.1 and 185 L/min; p=0.018). These results may suggest that wheelchair positioning aids can positively influence pulmonary function for non-ambulatory DMD patients.


Assuntos
Humanos , Criança , Adolescente , Distrofia Muscular de Duchenne/diagnóstico , Distrofia Muscular de Duchenne/genética , Equilíbrio Postural , Testes de Função Respiratória , Cadeiras de Rodas
8.
J Neurooncol ; 106(1): 71-9, 2012 Jan.
Artigo em Inglês | MEDLINE | ID: mdl-21725800

RESUMO

Aberrant expression of stem cell-related genes in tumors may confer more primitive and aggressive traits affecting clinical outcome. Here, we investigated expression and prognostic value of the neural stem cell marker CD133, as well as of the pluripotency genes LIN28 and OCT4 in 37 samples of pediatric medulloblastoma, the most common and challenging type of embryonal tumor. While most medulloblastoma samples expressed CD133 and LIN28, OCT4 expression was found to be more sporadic, with detectable levels occurring in 48% of tumors. Expression levels of OCT4, but not CD133 or LIN28, were significantly correlated with shorter survival (P ≤ 0.0001). Median survival time of patients with tumors hyperexpressing OCT4 and tumors displaying low/undetectable OCT4 expression were 6 and 153 months, respectively. More importantly, when patients were clinically stratified according to their risk of tumor recurrence, positive OCT4 expression in primary tumor specimens could discriminate patients classified as average risk but which further deceased within 5 years of diagnosis (median survival time of 28 months), a poor clinical outcome typical of high risk patients. Our findings reveal a previously unknown prognostic value for OCT4 expression status in medulloblastoma, which might be used as a further indicator of poor survival and aid postoperative treatment selection, with a particular potential benefit for clinically average risk patients.


Assuntos
Neoplasias Encefálicas/genética , Regulação Neoplásica da Expressão Gênica/genética , Regulação Neoplásica da Expressão Gênica/fisiologia , Meduloblastoma/genética , Fator 3 de Transcrição de Octâmero/biossíntese , Células-Tronco/fisiologia , Antígeno AC133 , Adolescente , Antígenos CD/biossíntese , Antígenos CD/genética , Malformação de Arnold-Chiari/genética , Biomarcadores , Neoplasias Encefálicas/tratamento farmacológico , Neoplasias Encefálicas/patologia , Criança , Pré-Escolar , Feminino , Glicoproteínas/biossíntese , Glicoproteínas/genética , Humanos , Estimativa de Kaplan-Meier , Masculino , Meduloblastoma/tratamento farmacológico , Meduloblastoma/patologia , Fator 3 de Transcrição de Octâmero/genética , Peptídeos/genética , Valor Preditivo dos Testes , Prognóstico , Proteínas de Ligação a RNA/biossíntese , Proteínas de Ligação a RNA/genética , Reação em Cadeia da Polimerase em Tempo Real , Medição de Risco , Sobrevida
9.
Stem Cell Rev Rep ; 7(4): 1006-17, 2011 Nov.
Artigo em Inglês | MEDLINE | ID: mdl-21503590

RESUMO

Pre-clinical studies have supported the use of mesenchymal stem cells (MSC) to treat highly prevalent neurodegenerative diseases such as Parkinson's disease (PD) but preliminary trials have reported controversial results. In a rat model of PD induced by MPTP neurotoxin, we first observed a significant bilateral preservation of dopaminergic neurons in the substantia nigra and prevention of motor deficits typically observed in PD such as hypokinesia, catalepsy, and bradykinesia, following intracerebral administration of human umbilical cord-derived MSC (UC-MSC) early after MPTP injury. However, surprisingly, administration of fibroblasts, mesenchymal cells without stem cell properties, as a xenotransplantation control was highly detrimental, causing significant neurodegeneration and motor dysfunction independently of MPTP. This observation prompted us to further investigate the consequences of transplanting a MSC preparation contaminated with fibroblasts, a plausible circumstance in cell therapy since both cell types display similar immunophenotype and can be manipulated in vitro under the same conditions. Here we show for the first time, using the same experimental model and protocol, that transplantation of UC-MSC induced potent neuroprotection in the brain resulting in clinical benefit. However, co-transplantation of UC-MSC with fibroblasts reverted therapeutic efficacy and caused opposite damaging effects, significantly exacerbating neurodegeneration and motor deficits in MPTP-exposed rats. Besides providing a rationale for testing UC-MSC transplantation in early phases of PD aiming at delaying disease progression, our pre-clinical study suggests that fibroblasts may be common cell contaminants affecting purity of MSC preparations and clinical outcome in stem cell therapy protocols, which might also explain discrepant clinical results.


Assuntos
Fibroblastos/citologia , Células-Tronco Mesenquimais/citologia , Fármacos Neuroprotetores/uso terapêutico , Transtornos Parkinsonianos/patologia , 1-Metil-4-Fenil-1,2,3,6-Tetra-Hidropiridina/farmacologia , Animais , Encéfalo/metabolismo , Encéfalo/patologia , Neurônios Dopaminérgicos/metabolismo , Fibroblastos/metabolismo , Humanos , Imuno-Histoquímica , Masculino , Transplante de Células-Tronco Mesenquimais , Células-Tronco Mesenquimais/metabolismo , Modelos Animais , Transtornos Parkinsonianos/terapia , Ratos , Ratos Wistar , Transplante Heterólogo , Cordão Umbilical/citologia
10.
Arq. neuropsiquiatr ; Arq. neuropsiquiatr;68(6): 947-952, Dec. 2010. ilus
Artigo em Inglês | LILACS | ID: lil-571339

RESUMO

Medulloblastoma is a highly malignant primary tumor of the central nervous system. It represents the most frequent type of solid tumor and the leading cause of death related to cancer in early childhood. Current treatment includes surgery, chemotherapy and radiotherapy which may lead to severe cognitive impairment and secondary brain tumors. New perspectives for therapeutic development have emerged with the identification of stem-like cells displaying high tumorigenic potential and increased radio- and chemo-resistance in gliomas. Under the cancer stem cell hypothesis, transformation of neural stem cells and/or granular neuron progenitors of the cerebellum are though to be involved in medulloblastoma development. Dissecting the genetic and molecular alterations associated with this process should significantly impact both basic and applied cancer research. Based on cumulative evidences in the fields of genetics and molecular biology of medulloblastomas, we discuss the possible involvement of developmental signaling pathways as critical biochemical switches determining normal neurogenesis or tumorigenesis. From the clinical viewpoint, modulation of signaling pathways such as TGFβ, regulating neural stem cell proliferation and tumor development, might be attempted as an alternative strategy for future drug development aiming at more efficient therapies and improved clinical outcome of patients with pediatric brain cancers.


Meduloblastoma é um tumor maligno do sistema nervoso central (SNC). Na infância, representa o tumor sólido mais frequente e a principal causa de morte relacionada ao câncer. Tratamentos atuais incluem cirurgia, quimioterapia e radioterapia, que podem trazer prejuízos cognitivos e desenvolvimento de tumores secundários. Novas perspectivas terapêuticas surgem com a identificação de células-tronco em gliomas, as quais apresentam alto potencial tumorigênico e maior resistência à radioterapia e quimioterapia. A hipótese das células-tronco tumorais sugere que a transformação de células-tronco e/ou progenitores neurais do cerebelo está envolvida no desenvolvimento do meduloblastoma. Portanto, analisar alterações genéticas e moleculares envolvidas nesse processo é de grande importância na pesquisa básica e aplicada ao câncer. Nesse sentido, discutimos o possível envolvimento de vias de sinalização bioquímica críticas a ambos os processos de neurogênese normal ou tumorigênese, com base em evidências atuais na área de genética e biologia molecular dos meduloblastomas. Do ponto de vista clínico, a modulação de vias de sinalização como a do TGFβ, regulando proliferação de célula-tronco neural e desenvolvimento tumoral, pode ser uma estratégia alternativa para o desenvolvimento de novos medicamentos objetivando-se terapias mais eficientes e melhora do prognóstico dos pacientes pediátricos com câncer de SNC.


Assuntos
Humanos , Neoplasias Cerebelares/patologia , Meduloblastoma/patologia , Células-Tronco Neoplásicas/patologia , Células-Tronco Neurais/patologia , Transdução de Sinais , Fator de Crescimento Transformador beta , Neoplasias Cerebelares/etiologia , Neoplasias Cerebelares/genética , Meduloblastoma/etiologia , Meduloblastoma/genética , Transdução de Sinais/genética , Fator de Crescimento Transformador beta/genética
11.
Arq Neuropsiquiatr ; 68(6): 947-52, 2010 Dec.
Artigo em Inglês | MEDLINE | ID: mdl-21243257

RESUMO

Medulloblastoma is a highly malignant primary tumor of the central nervous system. It represents the most frequent type of solid tumor and the leading cause of death related to cancer in early childhood. Current treatment includes surgery, chemotherapy and radiotherapy which may lead to severe cognitive impairment and secondary brain tumors. New perspectives for therapeutic development have emerged with the identification of stem-like cells displaying high tumorigenic potential and increased radio- and chemo-resistance in gliomas. Under the cancer stem cell hypothesis, transformation of neural stem cells and/or granular neuron progenitors of the cerebellum are though to be involved in medulloblastoma development. Dissecting the genetic and molecular alterations associated with this process should significantly impact both basic and applied cancer research. Based on cumulative evidences in the fields of genetics and molecular biology of medulloblastomas, we discuss the possible involvement of developmental signaling pathways as critical biochemical switches determining normal neurogenesis or tumorigenesis. From the clinical viewpoint, modulation of signaling pathways such as TGFß, regulating neural stem cell proliferation and tumor development, might be attempted as an alternative strategy for future drug development aiming at more efficient therapies and improved clinical outcome of patients with pediatric brain cancers.


Assuntos
Neoplasias Cerebelares/patologia , Meduloblastoma/patologia , Células-Tronco Neoplásicas/patologia , Células-Tronco Neurais/patologia , Transdução de Sinais , Fator de Crescimento Transformador beta , Neoplasias Cerebelares/etiologia , Neoplasias Cerebelares/genética , Humanos , Meduloblastoma/etiologia , Meduloblastoma/genética , Transdução de Sinais/genética , Fator de Crescimento Transformador beta/genética
12.
J Stem Cells ; 5(3): 103-11, 2010.
Artigo em Inglês | MEDLINE | ID: mdl-22314826

RESUMO

Isolation of highly tumorigenic stem-like cells from human glioblastoma specimens and cell lines has been focusing on their neural stem cells properties or capacity to efflux fluorescent dyes. Here, we report that, under standard culture conditions, human glioblastoma cells of the U87MG cell line display a predominant mesenchymal phenotype and share some of the in vitro properties of mesenchymal stem cells. Moreover, these cells were capable of forming tumors in immunocompetent rats. Infiltrative intracranial tumors could be detected 15 to 30 days post-stereotaxic cell injection within the motor cortex. Tumors were comprised by pleomorphic and mitotically active cells and displayed necrotic and hemorrhagic foci, which are common features of human glioblastomas. This rather unexpected in vivo tumorigenesis in the absence of immune suppression more closely mimics the physiological milieu encountered by tumor cells and could be explored as a xenograft orthotopic model of human glioblastomas to address new therapeutic approaches, particularly those involving immune effector mechanisms.


Assuntos
Neoplasias Encefálicas/patologia , Glioblastoma/patologia , Imunocompetência , Células-Tronco Mesenquimais/patologia , Animais , Diferenciação Celular , Forma Celular , Condrogênese/fisiologia , Humanos , Imunocompetência/fisiologia , Masculino , Células-Tronco Mesenquimais/fisiologia , Transplante de Neoplasias , Osteogênese/fisiologia , Ratos , Ratos Wistar , Transplante Heterólogo , Células Tumorais Cultivadas
13.
Fisioter. pesqui ; 16(3): 229-232, jul.-set. 2009. tab
Artigo em Português | LILACS | ID: lil-539082

RESUMO

Este estudo visou determinar a influência da adequação postural em cadeira de rodas na função respiratória de pacientes com amiotrofia espinhal tipo II (AME). Doze pacientes (idades entre 7 e 24 anos) com diagnóstico de AME II, confirmado por achados clínicos e análise genética, participaram do estudo. Os parâmetros respiratórios – volume minuto (VM), volume corrente (VC), capacidade vital forçada (CVF), pressões inspiratória (PImáx) e expiratória (PEmáx) máximas e pico de fluxo expiratório (PFE) – na cadeira de rodas individual, com adaptações, e em uma cadeira de rodas padrão, isto é, sem reclinação ou inclinação. Os resultados mostram valores melhores estatisticamente significativos de todos os parâmetros respiratórios (VM, p=0,002; VC, p=0,003; CVF, p=0,017; PImax, p=0,002; PEmax, p=0,006; e PFE, p=0,007) nas medidas tomadas na cadeira adaptada para a postura adequada. Os resultados permitem concluir que a adequação postural em cadeira de rodas influencia positivamente a função respiratória de pacientes com AME tipo II...


This study aimed at determining the influence of adequate wheelchair positioning aids on the respiratory function in spinal muscular atrophy (SMA) type-II patients. Twelve patients (aged 7 to 24) with SMA diagnosed by clinical findings and confirmed by genetic analysis, who owned wheelchairs with positioning aids, underwent spirometric assessment – as to minute volume (MV), tidal volume (TV), forced vital capacity (FVC), maximum inspiratory (IPmax) and expiratory (EPmax) pressures, and peak expiratory flow (PEF) – both on their own wheelchair and on a standard wheelchair with no recline or tilt. Results show significantly better values in all assessed parameters (MV, p=0.002; TV, p=0.003; FVC, p=0.017; IPmax, p=0.002, EPmax, p=0.006; and PEF, p=0.007) of measures taken at the patient’s own chair, with positioning aids. These results allow for concluding that wheelchair positioning aids may positively influence pulmonary function of SMA type II patients.


Assuntos
Humanos , Criança , Adolescente , Adulto , Atrofia Muscular Espinal , Postura , Sistema Respiratório , Cadeiras de Rodas
14.
Acta fisiátrica ; 15(4): 263-266, dez. 2008. ilus, tab
Artigo em Português | LILACS | ID: lil-514986

RESUMO

O acidente vascular encefálico (AVE) encontra-se como um dos principais problemas de saúde em todo mundo, tornando-se Brasil responsável por 17% dos casos de doenças cardiovasculares. Em decorrência disto o paciente apresenta desordens física, psicoafetiva, cognitiva e a espasticidade que dificulta a atividade motora voluntária, provocando redução na força muscular, influenciando diretamente na independência e funcionalidade. A toxina botulínica tipo A (TBA) além de proporcionar um relaxamento da musculatura espástica, promove possibilidade de reajuste de um padrão funcional e associado a isso está a utilização do dinamômetro isocinético, o qual possibilita após algumas sessões, redução da hipertonia e o treinamento da musculatura antagonista. Baseando-se nestas informações, o presente estudo tem como objetivo analisar a eficiência do treinamento com dinamômetro isocinético no desempenho muscular dos dorsiflexores espásticos de paciente com seqüela de AVE após infiltração de TBA. Foi realizado um estudo de caso, sujeito do sexo masculino, hemiparético à direita, que realizou 10 sessões de treino no Cybex Humac Norm®, com uma avaliação pré e pós-treinamento e logo após a primeira infiltração de TBA. O resultado deste estudo demonstrou melhora na força, trabalho total, torque e potência da musculatura em treinamento excêntrico dos dorsiflexores e diminuição do déficit de força muscular entre os membros inferiores. Concluiu-se que a TBA com seu efeito relaxante sobre musculatura espástica possibilitou uma reeducação neuromuscular e melhora do controle motor seletivo, permitindo o aperfeiçoamento do desempenho muscular dos dorsiflexores por meio da dinamometria isocinética em baixas velocidades angulares, tanto do modo excêntrico quanto concêntrico. Torna-se necessário, com a escassez de dados na literatura, um estudo mais abrangente, com maior número de sujeitos e grupo controle.


Assuntos
Humanos , Masculino , Pessoa de Meia-Idade , Espasticidade Muscular/etiologia , Espasticidade Muscular/fisiopatologia , Paresia , Toxinas Botulínicas Tipo A/uso terapêutico , Acidente Vascular Cerebral/complicações , Terapia por Exercício , Tono Muscular/fisiologia
15.
Acta fisiátrica ; 15(4): 267-268, dez. 2008. graf
Artigo em Português | LILACS | ID: lil-514987

RESUMO

Os distúrbios do equilíbrio compõem um dos fatores etiológicos centrais das quedas e da instabilidade em idosos, podendo levar a incapacidade funcional e dependência e, por isso vêm sendo utilizados como marcadores de fragilidade. Considerando que a prevenção e a reabilitação do declínio do equilíbrio em idosos requerem o desenvolvimento de protocolos de pesquisa adequados para se medir a função do equilíbrio, este trabalho teve como objetivo analisar e comparar a eficácia de três instrumentos de avaliação utilizados para identificar o risco de queda em idosos. Para isso, a Escala de equilíbrio de Berg (EEB), o Teste Timed Up & Go (TUG) e o Índice de Marcha Dinâmico (IMD) foram aplicados em sete idosos hígidos. A análise dos resultados revelou que as escalas utilizadas são de fácil aplicação e entendimento, não havendo necessidade de treinamento do avaliador. No entanto, como as três escalas avaliam aspectos distintos, foi possível identificar, na população avaliada, risco de queda aumentado em quatro idosos apenas por meio do IMD


Assuntos
Humanos , Masculino , Feminino , Idoso , Equilíbrio Postural/fisiologia , Marcha/fisiologia , Postura , Pesos e Medidas
SELEÇÃO DE REFERÊNCIAS
DETALHE DA PESQUISA